Joanne Wuensch
Stock Analyst at Citigroup
(4.39)
# 328
Out of 4,896 analysts
397
Total ratings
64.66%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Neutral | $320 → $285 | $237.94 | +19.78% | 25 | Jul 9, 2025 | |
| MDT Medtronic | Maintains: Buy | $98 → $99 | $89.92 | +10.10% | 20 | Jul 9, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $86 → $89 | $75.13 | +18.46% | 5 | Jul 9, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $38 → $47 | $44.89 | +4.70% | 7 | Jul 9, 2025 | |
| BAX Baxter International | Maintains: Neutral | $34 → $32 | $28.70 | +11.50% | 21 | Jul 9, 2025 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $13 → $15 | $13.88 | +8.07% | 6 | Jul 9, 2025 | |
| HAE Haemonetics | Upgrades: Buy | $71 → $90 | $75.52 | +19.17% | 8 | Jul 9, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Sell | $24 → $14 | $15.59 | -10.20% | 17 | Jul 9, 2025 | |
| SYK Stryker | Maintains: Buy | $443 → $455 | $389.46 | +16.83% | 14 | May 22, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.2 → $3.6 | $3.41 | +5.57% | 11 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.90 | +43.10% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $167 | $135.74 | +23.03% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $512.06 | +26.94% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $289.32 | +31.34% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $78.05 | +21.72% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $102 | $83.37 | +22.35% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $103.20 | +21.12% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $119.96 | +16.71% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $74.77 | +47.12% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $132.02 | +21.19% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $175 | $156.90 | +11.54% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $103.81 | +56.05% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $12.59 | +74.74% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $93.79 | +27.95% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $175.97 | +42.07% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $87.48 | -21.12% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $254.40 | -50.08% | 6 | Dec 10, 2018 |
Penumbra
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $237.94
Upside: +19.78%
Medtronic
Jul 9, 2025
Maintains: Buy
Price Target: $98 → $99
Current: $89.92
Upside: +10.10%
GE HealthCare Technologies
Jul 9, 2025
Maintains: Buy
Price Target: $86 → $89
Current: $75.13
Upside: +18.46%
Establishment Labs Holdings
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $44.89
Upside: +4.70%
Baxter International
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $28.70
Upside: +11.50%
Bausch + Lomb
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $13.88
Upside: +8.07%
Haemonetics
Jul 9, 2025
Upgrades: Buy
Price Target: $71 → $90
Current: $75.52
Upside: +19.17%
Tandem Diabetes Care
Jul 9, 2025
Downgrades: Sell
Price Target: $24 → $14
Current: $15.59
Upside: -10.20%
Stryker
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $389.46
Upside: +16.83%
Sight Sciences
May 22, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $3.41
Upside: +5.57%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.90
Upside: +43.10%
May 22, 2025
Maintains: Buy
Price Target: $130 → $167
Current: $135.74
Upside: +23.03%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $512.06
Upside: +26.94%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $289.32
Upside: +31.34%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $78.05
Upside: +21.72%
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $83.37
Upside: +22.35%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $103.20
Upside: +21.12%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $119.96
Upside: +16.71%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $74.77
Upside: +47.12%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $132.02
Upside: +21.19%
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $156.90
Upside: +11.54%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $103.81
Upside: +56.05%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $12.59
Upside: +74.74%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $93.79
Upside: +27.95%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $175.97
Upside: +42.07%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $87.48
Upside: -21.12%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $254.40
Upside: -50.08%